These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24858481)

  • 1. Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally.
    Carballo-Diéguez A; Giguere R; Dolezal C; Bauermeister J; Leu CS; Valladares J; Rohan LC; Anton PA; Cranston RD; Febo I; Mayer K; McGowan I
    AIDS Behav; 2014 Sep; 18(9):1734-45. PubMed ID: 24858481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator Satisfaction Among Young Men Who Have Sex With Men.
    Bauermeister J; Giguere R; Dolezal C; Leu CS; Febo I; Cranston RD; Mayer K; McGowan I; Carballo-Diéguez A
    AIDS Educ Prev; 2016 Feb; 28(1):1-10. PubMed ID: 26829253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Supporting and Hindering Adherence to Rectal Microbicide Gel Use with Receptive Anal Intercourse in a Phase 2 Trial.
    Giguere R; Rael CT; Sheinfil A; Balán IC; Brown W; Ho T; Dolezal C; Leu CS; Liu A; Mayer KH; Lama JR; McGowan I; Carballo-Diéguez A; Cranston RD;
    AIDS Behav; 2018 Feb; 22(2):388-401. PubMed ID: 28825142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research.
    Carballo-Diéguez A; Giguere R; Dolezal C; Bauermeister J; Leu CS; Valladares J; Frasca T; Labbett R; Cranston RD; Febo I; Mayer K; McGowan I
    AIDS Behav; 2014 Sep; 18(9):1726-33. PubMed ID: 24719200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial.
    Pines HA; Gorbach PM; Weiss RE; Hess K; Murphy R; Saunders T; Brown J; Anton PA; Cranston RD
    AIDS Behav; 2013 Mar; 17(3):1002-15. PubMed ID: 23114512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men.
    Bauermeister JA; Giguere R; Leu CS; Dolezal C; Febo I; Cranston RD; Mayer K; McGowan I; Carballo-Diéguez A
    AIDS Behav; 2018 Feb; 22(2):412-420. PubMed ID: 28688029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel.
    Cohen JA; Brache V; Foster J; Cochon L; Callahan M; Schwartz J
    Sex Transm Dis; 2013 Jun; 40(6):476-81. PubMed ID: 23677021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and feasibility of Micralax applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides.
    Coetzee N; Blanchard K; Ellertson C; Hoosen AA; Friedland B
    AIDS; 2001 Sep; 15(14):1837-42. PubMed ID: 11579246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Like Holding an Umbrella Before It Rains": Acceptability of Future Rectal Microbicides Among Men Who Have Sex With Men in India-A Modified Technology Acceptance Model.
    Chakrapani V; Newman PA; Shunmugam M; Mengle S; Nelson R; Rubincam C; Kumar P
    Qual Health Res; 2017 Jul; 27(8):1236-1248. PubMed ID: 28682740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.
    Carballo-Diéguez A; Giguere R; Dolezal C; Chen BA; Kahn J; Zimet G; Mabragaña M; Leu CS; McGowan I
    AIDS Behav; 2012 Oct; 16(7):1761-74. PubMed ID: 21863338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Partner Type on Acceptability and Likelihood of Use of a Rectal Microbicide Among Young Men Who Have Sex With Men in the United States and Puerto Rico.
    Giguere R; Dolezal C; Bauermeister JA; Frasca T; Valladares J; Febo I; Cranston RD; Mayer K; McGowan I; Carballo-Diéguez A
    J Sex Res; 2016; 53(6):633-41. PubMed ID: 26132717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTN-033: a Phase 1 Study Comparing Applicator versus "as Lubricant" Delivery of Rectal Dapivirine Gel.
    Ho K; Dominguez-Islas C; Szydlo D; Edick S; Macagna N; Riddler SA; Brand RM; Jacobson CE; Kramzer L; Kunjara Na Ayudhya RP; Piper J; Marzinke MA; Bauermeister J; Nuttall J; Hillier SL; Hendrix CW
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0081622. PubMed ID: 36255254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.
    Giguere R; Carballo-Diéguez A; Ventuneac A; Mabragaña M; Dolezal C; Chen BA; Kahn JA; Zimet GD; McGowan I
    Cult Health Sex; 2012; 14(2):151-66. PubMed ID: 22084840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Ouellet C; Danylo A; Ong T; Bergeron MG
    J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of the dye-based method for determining vaginal applicator use in microbicide trials.
    Austin MN; Rabe LK; Hillier SL
    Sex Transm Dis; 2009 Jun; 36(6):368-71. PubMed ID: 19556930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lubricant Provides Poor Rectal Mucosal HIV Coverage.
    Shieh EC; Weld ED; Fuchs EJ; Hiruy H; Buckheit KW; Buckheit RW; Breakey J; Hendrix CW
    AIDS Res Hum Retroviruses; 2017 Aug; 33(8):784-787. PubMed ID: 28649870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.
    Rosen RK; Morrow KM; Carballo-Diéguez A; Mantell JE; Hoffman S; Gai F; Maslankowski L; El-Sadr WM; Mayer KH
    J Womens Health (Larchmt); 2008 Apr; 17(3):383-92. PubMed ID: 18328009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
    Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
    [No Abstract]   [Full Text] [Related]  

  • 19. Couples' acceptability of the SILCS diaphragm for microbicide delivery.
    Frezieres RG; Walsh T; Kilbourne-Brook M; Coffey PS
    Contraception; 2012 Jan; 85(1):99-107. PubMed ID: 22067809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery.
    Beksinska M; Greener R; Smit J; Maphumulo B; Mphili N; Kilbourne-Brook M; Coffey PS
    AIDS Behav; 2018 Jan; 22(1):127-132. PubMed ID: 28993940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.